clinical-trial is the sole category represented across all 1 tracked stories. AACR Annual Meeting is most often covered alongside Jazz Pharmaceuticals, which appears in 1 of these 1 story. AACR Annual Meeting appears in 1 tracked Biotech story from March 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about AACR Annual Meeting
clinical-trial is the sole category represented across all 1 tracked stories. AACR Annual Meeting is most often covered alongside Jazz Pharmaceuticals, which appears in 1 of these 1 story. AACR Annual Meeting appears in 1 tracked Biotech story from March 18, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering AACR Annual Meeting. Shared-story counts are live from our verified record — not editorial picks.
Zymeworks Inc. (ZYME) has announced multiple upcoming presentations for its lead asset, Ziihera (zanidatamab-hrii), at the 2026 AACR Annual Meeting. These presentations are expected to showcase the therapeutic's efficacy and safety across various HER2-expressing cancers, reinforcing its position in the competitive oncology landscape.
AACR Annual Meeting is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.